Latest filing published 02 Oct 2026 for Cutia Therapeutics - B.
No signal scores available.
Huang Yuqing is a declared insider of Cutia Therapeutics - B, with filings sourced from HKEX. The record holds 7 filings, for trades running from 12 June 2023 to 30 September 2026.
The open-market record is one-sided, with 3 purchases worth €137k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €49k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 2 October 2026 came the latest disclosure, a transaction in Cutia Therapeutics - B. The most recent open-market purchase was published on 8 October 2024, 748 days ago. The median gap between a trade and its publication by HKEX is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations